5
Views
4
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Organ failure in acute pancreatitis

Pages 171-175 | Published online: 11 Jul 2009
 

Abstract

Organ dysfunction or organ failure is a common clinical feature of acute pancreatitis (AP). The threshold for definition of organ failure adopted at the International Symposium on Acute Pancreatitis held in Atlanta, GA in 1992 was set at significant impairment of organ or system function. Intensive care practitioners have developed a number of different scoring scales for organ dysfunction, which allow grading of its severity. In AP, prognosis deteriorates progressively with an increase in the number of systems involved, but according to currently accepted definitions any patient with any organ failure is classified as having severe AP. Almost half of patients with predicted severe disease have organ failure at the time of admission to hospital. It is now clear that many patients with early organ failure recover without further complications. Organ failure during the first week of AP can regress, with subsequent very low mortality, but if the organ failure persists to the end of the first week the outlook is extremely poor. Organ failure which resolves within 48 h of onset is associated with a very low mortality. By contrast, organ failure which persists for >48 h is associated with a 35% mortality rate. Early organ failure (at the time of admission to hospital) is associated with an increased risk of pancreatic necrosis. It seems reasonable to suppose that the extent of pancreatic injury may directly determine the severity and duration of the inflammatory response. The presence of persistent organ failure is clearly associated with the presence of local complications. The association between persistent organ failure and subsequent fatal outcome and the low mortality rate in patients with transient organ failure suggest that, if organ failure is present early during AP, aggressive treatment to reverse the organ failure may have a protective effect and could improve outcome.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.